Eric K. Rowinsky
2015
In 2015, Eric K. Rowinsky earned a total compensation of $1.6M as Former Executive Vice President, Chief Medical Officer and Head of Research and Development at Stemline Therapeutics, a 7% decrease compared to previous year.
Compensation breakdown
| Option Awards | $768,029 |
|---|---|
| Salary | $341,250 |
| Stock Awards | $383,969 |
| Other | $81,345 |
| Total | $1,574,593 |
Rowinsky received $768K in option awards, accounting for 49% of the total pay in 2015.
Rowinsky also received $341.3K in salary, $384K in stock awards and $81.3K in other compensation.
Rankings
In 2015, Eric K. Rowinsky's compensation ranked 5,738th out of 13,638 executives tracked by ExecPay. In other words, Rowinsky earned more than 57.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,738 out of 13,638 | 58th |
Division Manufacturing | 2,140 out of 5,190 | 59th |
Major group Chemicals And Allied Products | 769 out of 1,854 | 59th |
Industry group Drugs | 611 out of 1,528 | 60th |
Industry Pharmaceutical Preparations | 480 out of 1,182 | 59th |
Source: SEC filing on April 8, 2016.
Rowinsky's colleagues
We found three more compensation records of executives who worked with Eric K. Rowinsky at Stemline Therapeutics in 2015.